AstraZeneca abandons U.S. application for COVID-19 vaccine, halts development of multiple drugs
ADC评论
November 11, 2022
On November 10, when AstraZeneca announced its third-quarter 2022 results, it also announced that it would not submit a listing application for the new crown
